Newsfeeds - Spark Newswire

1 minute read

News

TG Therapeutics Announces Combination Data Presentations At The XIX International Workshop On Chronic Lymphocytic Leukemia

Today, 7:39 PM

TG Therapeutics, Inc. (NASDAQ:TGTX), today announced data presentations at the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL). Data highlights from each presentation are included below. The Company

TGTX

4 minute read

The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight

By Shanthi Rexaline

Today, 7:39 PM

Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical readouts and IPOs were among the catalysts for the week.

AGTC

5 minute read

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera’s COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold

By Shanthi Rexaline

Today, 7:39 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16)

ABCL

4 minute read

The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs

By Shanthi Rexaline

Today, 7:39 PM

Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week.

ALRN

2 minute read

Understanding TG Therapeutics’s Unusual Options Activity

By Benzinga Insights

Today, 7:39 PM

TG Therapeutics (NASDAQ:TGTX) shares experienced unusual options activity on Monday. The stock price moved down to $22.62 following the option alert.

TGTX

1 minute read

Earnings

Looking into TG Therapeutics’s Return on Capital Employed

By Benzinga Insights

Today, 7:39 PM

After pulling data from Benzinga Pro it seems like during Q2, TG Therapeutics (NASDAQ:TGTX) posted sales of $1.54 million. Earnings were up 13.36%, but TG Therapeutics still reported an overall loss of $76.87 million.

TGTX

5 minute read

61 Biggest Movers From Yesterday

By Lisa Levin

Today, 7:39 PM

Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 124.8% to close at $5.08 on Monday after the company announced a $5 million stock repurchase program.

ACY

1 minute read

TG Therapeutics Stock Plunged As H.C. Wainwright Cuts Target Price After Disappointing Q2

By Vandana Singh

Today, 7:39 PM

H.C. Wainwright has lowered TG Therapeutics Inc’s (NASDAQ:TGTX) price target to $84 from $89 and keeps a Buy rating on the stock. Analyst Edward…

TGTX

3 minute read

Mid-Afternoon Market Update: Nasdaq Gains 50 Points; Marin Software Shares Plummet

By Lisa Levin

Today, 7:39 PM

Toward the end of trading Monday, the Dow traded up 0.02% to 34,941.69 while the NASDAQ rose 0.37% to 14,727.42. The S&P also rose, gaining 0.10% to 4,399.45.

ELA

1 minute read

HC Wainwright & Co. Maintains Buy on TG Therapeutics, Lowers Price Target to $84

By Benzinga Newsdesk

Today, 7:39 PM

HC Wainwright & Co. analyst Edward White maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and lowers the price target from $89 to $84.

TGTX